Study Type definition

Study Type means the nature of the investigation or investigational use for which clinical trial information is being submitted, e.g., interventional, observational.
Sample 1Sample 2Sample 3
Study Type. Rio Puerco Expansion (TP-2008-01) Requestor: PNM
Sample 1Sample 2
Study Type. Installation of a 25 Mar Shunt Capacitor Bank (TP-2008-05) Requestor: PNM Location: Yah-Ta- Hey Switching Station
Sample 1Sample 2

Examples of Study Type in a sentence

  • Low Income Hours of Use and Heating Study Type of Study: Impact EvaluationEvaluation Conducted by: The Cadmus Group, Inc.Date Evaluation Completed: 6/28/2013 Evaluation Objective and High Level Findings: The objective of the study is to assess lighting hours of use (HOU) and the prevalence of secondary heating among low income customers.

  • INCITS project types are defined below.• Study (Type S) Project: Study projects are to determine the feasibility and need for a development project which has been proposed to INCITS.

  • Phase I and II engineering services are required for the preparation of a Structure Geotechnical Report, Wall Type Study, Type, Size and Location (TS&L) and final contract plans, specifications and cost estimates for retaining walls located along Illinois Route 29 from Gardner Lane in Peoria Heights to the McClugage Bridge in Peoria.

  • In the screening phase, phase ii) retrieved citations were screened for possible inclusion based on ‘title and abstract’ using the Participants, Exposure, Outcomes, Study Type (PEOS) criteria for guidance.

  • STAFFOriginal Study : Funded/Not Funded Any Other Study Type (Please Specify) :IIIPROTOCOL CHECKLIST (Tick the relevant boxes) A.

  • Acute Toxicity Profile of Ammonium Thiosulfate Guideline Number Study Type MRID(s) Results Toxicity Category polypnea and dyspnea, languid behavior, hunched appearance, prostration and tremors, rhinorrhea, chromodacryorrhea, and salivation.

  • This data element is only applicable for Expanded Access records (see Expanded Access under Study Type).

  • Level of Education:Secondary Education Bachelor MasterOther Course of Study Type of Education: Preparatory training BachelorSeat of Educational Institution:3.

  • Summary of discharge planning review studies Authors (Year) Study Type Study Objective Braet et al., 2016 Systematic review & meta analysis (47 RCTs) To identify discharge interventions from hospital to home that reduce hospital re-admissions within three months.

  • Study Type should default to Diagnostic, Study Length to 1-night, and Select Group to Bronx, Chicago, Miami or San Diego.


More Definitions of Study Type

Study Type. Expansion/Upgrade of the Xxxxxxx 115 kV Station (TP-2008-07) Requestor: PNM Study Type: Xxxxxxx Substation (TP-2008-09) Requestor: PNM
Sample 1Sample 2
Study Type. Red Mesa Switching Station (TP-2010-01) Requestor: PNM
Sample 1Sample 2
Study Type. A Single Dose Pharmacokinetic Study of Recombinant Human Growth Factor (FGF-1) in Rats
Sample 1

Related to Study Type

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Phase 3 means the period commencing on the day after the Phase 2 implementation date and ending on the Phase 3 implementation date (as defined below).

  • Phase 1 Trial means, with respect to a Licensed Product, a clinical trial (or — in case of a multi-phase clinical trial — those parts of a clinical trial) in line with the provisions of 21CFR312, Section 21 (a).

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.

  • Phase 1 means the phase of the ATP comprised of: (1) improvements to the State Street Substation; (2) construction of the Proposed Line; (3) the rebuilding of NYSEG’s existing Lines 971 and 000 xxxxx xx Xxxxxxxx Xxxx xx the NYSEG ROW to allow for construction of the Proposed Line as intended; (4) improvements to the Elbridge Substation to accept the Proposed Line; and (5) National Grid’s conveyance to NYSEG of the NYSEG Acquired ROW and such other land interests as contemplated by the Purchase and Sale Agreement.

  • Tests after Completion means the tests (if any) which are specified in the Contract and which are carried out in accordance with the Specification after the Works or a Section (as the case may be) are taken over by the Procuring Entity.

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Treatability study means a study in which a hazardous waste is subjected to a treatment process to determine: (1) Whether the waste is amenable to the treatment process, (2) what pretreatment (if any) is required, (3) the optimal process conditions needed to achieve the desired treatment, (4) the efficiency of a treatment process for a specific waste or wastes, or (5) the characteristics and volumes of residuals from a particular treatment process. Also included in this definition for the purpose of the § 261.4 (e) and (f) exemptions are liner compatibility, corrosion, and other material compatibility studies and toxicological and health effects studies. A “treatability study” is not a means to commercially treat or dispose of hazardous waste.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Timeline means the list of critical dates and actions included in the Introductory Materials.

  • Phase 1 Study means a clinical study of a drug candidate in human patients with the primary objective of characterizing its safety, tolerability, and pharmacokinetics and identifying a recommended dose and regimen for future studies as described in 21 C.F.R. §312.21(a), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The drug candidate can be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Study Completion means the database for the Study has been locked and all Essential Documents have been provided to the Sponsor, including a copy of the letter from the Reviewing HREC acknowledging receipt of the final report and/or closure letter from the Principal Investigator.

  • Clinical Trial means any human clinical trial of a Product.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase III means human clinical trials, the principal purpose of which is to establish substantial evidence of both safety and efficacy in patients with the disease or condition being studied, as more fully defined in 21 C.F.R. §312.21(c) or similar clinical study in a country other than the United States. Phase III shall also include any other human clinical trial intended to serve as a pivotal trial to support the submission of an application for regulatory approval.

  • Screening means the evaluation process used to identify an individual's ability to perform activities of daily living and address health and safety concerns.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • Risk assessment means a programme to determine any risk associated with any hazard at a construction site , in order to identify the steps needed to be taken to remove, reduce or control such hazard;

  • Acceptance Testing mean the tests, reviews and other activities that are performed by or on behalf of Agency to determine whether the Deliverables meet the Acceptance Criteria or otherwise satisfy the Agency, as determined by the Agency in its sole discretion.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Diagnosis of autism spectrum disorder means medically necessary assessments, evaluations, or tests

  • Phase 2 means the phase of the ATP comprised of: (1) improvements to the State Street Substation to receive Rebuilt Line 972; (2) the rebuilding of NYSEG’s existing Line 972 not performed in Phase 1; (3) construction of Relocated Line 15; (4) the construction of Bused Line 5; (5) improvements to the Elbridge Substation to receive Relocated Line 15; and (6) improvements to the Elbridge Substation to receive Bused Line 5.